---
schema_version: "secwatch.filing_event.v1"
accession: "0000818479-25-000167"
form_type: "8-K"
ticker: "XRAY"
cik: "0000818479"
company_name: "DENTSPLY SIRONA Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:48:43.824523+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dentsply Sirona Retains Wellspect Healthcare After Strategic Review, Ends Sale Process

## Summary
- Strategic review of Wellspect begun Feb 2025 completed Sep 8, 2025; company decided to retain the business.
- Wellspect is a leader in continence care with LoFric and Navina brands; mid-single digit organic sales growth in 2024.
- CEO Dan Scavilla cited strong cash flow, untapped market potential, and a $2B addressable market for the decision.
- Company conducted broad outreach and considered a sale but determined retention creates more stockholder value.

## SEC filing metadata
- accession: 0000818479-25-000167
- form_type: 8-K
- ticker: XRAY
- cik: 0000818479
- company_name: DENTSPLY SIRONA Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818479/000081847925000167/0000818479-25-000167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818479/000081847925000167/xray-20250908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000818479-25-000167
- JSON: https://secwatch.observer/filing/0000818479-25-000167.json
- Plain text: https://secwatch.observer/filing/0000818479-25-000167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.